<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Research Foundation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2011.00036</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Assembly and Biosynthesis of Acetylcholinesterase in Brain and Muscle: the Roles of t-peptide, FHB Domain, and N-linked Glycosylation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Vicky P.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Luk</surname> <given-names>Wilson K. W.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chan</surname> <given-names>Wallace K. B.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Leung</surname> <given-names>K. Wing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Guo</surname> <given-names>Ava J. Y.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chan</surname> <given-names>Gallant K. L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xu</surname> <given-names>Sherry L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Choi</surname> <given-names>Roy C. Y.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Tsim</surname> <given-names>Karl W. K.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001">&#x0002A;</xref>
<!-- http://www.frontiersin.org/Community/WhosWhoDetails.aspx?UID=28921&d=1&sname=KarlTsim&name=Science -->
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Division of Life Science, Center for Chinese Medicine, The Hong Kong University of Science and Technology</institution> <country>Hong Kong, China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Hermona Soreq, The Hebrew University of Jerusalem, Israel</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Ye He, University of California San Francisco, USA; Bon Suzanne, CNRS, France</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Karl W. K. Tsim, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay Road, Hong Kong SAR, China. e-mail: <email>botsim&#x00040;ust.hk</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>10</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="collection">
<year>2011</year>
</pub-date>
<volume>4</volume>
<elocation-id>36</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>07</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>10</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2011 Chen, Luk, Chan, Leung, Guo, Chan, Xu, Choi and Tsim.</copyright-statement>
<copyright-year>2011</copyright-year>
<license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><p>This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.</p></license>
</permissions>
<abstract>
<p>Acetylcholinesterase (AChE) is responsible for the hydrolysis of the neurotransmitter, acetylcholine, in the nervous system. The functional localization and oligomerization of AChE T variant are depending primarily on the association of their anchoring partners, either collagen tail (ColQ) or proline-rich membrane anchor (PRiMA). Complexes with ColQ represent the asymmetric forms (A<sub>12</sub>) in muscle, while complexes with PRiMA represent tetrameric globular forms (G<sub>4</sub>) mainly found in brain and muscle. Apart from these traditional molecular forms, a ColQ-linked asymmetric form and a PRiMA-linked globular form of hybrid cholinesterases (ChEs), having both AChE and BChE catalytic subunits, were revealed in chicken brain and muscle. The similarity of various molecular forms of AChE and BChE raises interesting question regarding to their possible relationship in enzyme assembly and localization. The focus of this review is to provide current findings about the biosynthesis of different forms of ChEs together with their anchoring proteins.</p>
</abstract>
<kwd-group>
<kwd>acetylcholinesterase</kwd>
<kwd>butyrylcholinesterase</kwd>
<kwd>assembly</kwd>
<kwd>membrane trafficking</kwd>
<kwd>glycosylation</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="70"/>
<page-count count="8"/>
<word-count count="6616"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction">
<title>Introduction</title>
<p>Cholinesterases (ChEs) are serine hydrolases that preferentially act on choline esters. Vertebrates possess two types of cholinesterases (ChEs), corresponding to two distinct genes: acetyl cholinesterase (AChE, EC 3.1.1.7) and butyryl cholinesterase (BChE, EC 3.1.1.8). These two enzymes are distinguished on the basis of the substrate specificities and their sensitivities to selective inhibitors (Mendel and Rudney, <xref ref-type="bibr" rid="B43">1943</xref>; Austin and Berry, <xref ref-type="bibr" rid="B1">1953</xref>). The primary function of AChE is to efficiently hydrolyze the neurotransmitter acetylcholine (ACh) at cholinergic synapses (Massouli&#x000E9; et al., <xref ref-type="bibr" rid="B41">1993</xref>), whereas the physiological function of BChE in vertebrates remains a question of different speculations. Studies of AChE knockout mice suggested that BChE can partially compensate for the absence of AChE in the nervous system (Xie et al., <xref ref-type="bibr" rid="B69">2000</xref>; Duysen et al., <xref ref-type="bibr" rid="B16">2001</xref>); therefore BChE could hydrolyze acetylcholine functionally. Poisoning by ChE inhibitors, such as insecticides or nerve gas, results in accumulation of ACh, and uncontrolled activation of cholinergic receptors, which causes cholinergic crisis and potentially leads to death (Feyereisen, <xref ref-type="bibr" rid="B21">1995</xref>; Bajgar, <xref ref-type="bibr" rid="B2">2004</xref>). On the other hand, controlled treatment with ChE inhibitors are used in therapeutics for patients suffering from myasthenia gravis (Brenner et al., <xref ref-type="bibr" rid="B8">2008</xref>; Mehndiratta et al., <xref ref-type="bibr" rid="B42">2011</xref>), Alzheimer&#x02019;s disease (Giacobini, <xref ref-type="bibr" rid="B23">2000</xref>; Stone et al., <xref ref-type="bibr" rid="B60">2011</xref>), and Parkinson&#x02019;s disease (Hutchinson and Fazzini, <xref ref-type="bibr" rid="B24">1996</xref>; Emre et al., <xref ref-type="bibr" rid="B18">2004</xref>).</p>
<p>In vertebrates, <italic>ACHE</italic> gene produces several types of coding sequences differing in an alternative choice of splice acceptor sites in the 3&#x02032; region. This process generates different AChE isoforms, named AChE<sub>R</sub>, AChE<sub>H</sub>, and AChE<sub>T</sub> (Massouli&#x000E9;, <xref ref-type="bibr" rid="B39">2002</xref>). They contain the same catalytic domain, but are associated with distinct C-terminal peptides. In contrast, <italic>BCHE</italic> gene produces single type of transcript and generates single type of isoform BChE<sub>T</sub> (Blong et al., <xref ref-type="bibr" rid="B4">1997</xref>). AChE and BChE are well-known for their multiple molecular forms that have their specific localizations: AChE<sub>R</sub> is a soluble monomer that is up-regulated in the brain under stress stimulation (Kaufer et al., <xref ref-type="bibr" rid="B26">1998</xref>; Perrier et al., <xref ref-type="bibr" rid="B50">2005</xref>); AChE<sub>H</sub> is a glycosylphosphatidylinositol-anchored dimer that is mainly expressed in red blood cells (Li et al., <xref ref-type="bibr" rid="B35">1991</xref>); AChE<sub>T</sub> and BChE<sub>T</sub> are present in collagen-tailed forms at the neuromuscular junction (nmj) and hydrophobic-tailed forms in the brain (Legay et al., <xref ref-type="bibr" rid="B33">1995</xref>; Blong et al., <xref ref-type="bibr" rid="B4">1997</xref>; Massouli&#x000E9; et al., <xref ref-type="bibr" rid="B40">2005</xref>). The molecular forms of AChE<sub>T</sub> and BChE<sub>T</sub> in brain and muscle are of particular interest because they are associated with their anchoring proteins: collagen Q (ColQ) or proline-rich membrane anchor (PRiMA). Complexes with ColQ represent the collagen-tailed or asymmetric (A) forms in muscle (Krejci et al., <xref ref-type="bibr" rid="B30">1997</xref>), while complexes with PRiMA represent membrane-bound tetrameric globular form (G<sub>4</sub>), mainly in brain (Perrier et al., <xref ref-type="bibr" rid="B48">2002</xref>, <xref ref-type="bibr" rid="B49">2003</xref>; Xie et al., <xref ref-type="bibr" rid="B65">2009</xref>) and muscle (Xie et al., <xref ref-type="bibr" rid="B66">2007</xref>). In addition, mixed cholinesterases, ColQ-linked AChE&#x02013;BChE A<sub>12</sub> hybrid enzyme (Tsim et al., <xref ref-type="bibr" rid="B62">1988a</xref>) and PRiMA-linked AChE&#x02013;BChE G<sub>4</sub> hybrid enzyme (Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>) that contain both AChE and BChE homodimers in a single molecule are being found in avian system. Here, we summarized the recent studies on the assembly of oligomeric AChE and BChE, as well as the regulation of AChE and/or BChE biosynthesis in neurons and muscles.</p>
</sec>
<sec>
<title>Molecular Forms of AChE and BChE in Brain and Muscle</title>
<sec>
<title>PRiMA-linked globular forms of ChEs</title>
<p>In <italic>Xenopus</italic> oocytes, COS-7 cells, neuroblastoma cells, and muscle cells, the expression of PRiMA has been identified as a limiting factor in organizing G<sub>4</sub> AChE and targeting it to the cell membrane (Perrier et al., <xref ref-type="bibr" rid="B48">2002</xref>; Xie et al., <xref ref-type="bibr" rid="B66">2007</xref>), as well as in directing its membrane raft localization (Xie et al., <xref ref-type="bibr" rid="B67">2010a</xref>). In the absence of PRiMA, the G<sub>4</sub> AChE, or the G<sub>4</sub> BChE, could not be formed. In the brain, the catalytic subunit contained in G<sub>4</sub> AChE is AChE<sub>T</sub> (Inestrosa et al., <xref ref-type="bibr" rid="B25">1994</xref>). The expression of PRiMA mRNA and protein are increased with an increment of G<sub>4</sub> AChE during the development of brain and spinal cord (Leung et al., <xref ref-type="bibr" rid="B34">2009</xref>; Xie et al., <xref ref-type="bibr" rid="B68">2010b</xref>). The PRiMA-linked AChE is also present at the nmj, in which both motor neuron and muscle are the major suppliers. In rat muscles, the protein expression of PRiMA and AChE<sub>T</sub>, as well as the G<sub>4</sub> AChE, are dramatically increased during development (Leung et al., <xref ref-type="bibr" rid="B34">2009</xref>). The parallel expression of PRiMA and G<sub>4</sub> AChE during the development strengthens the importance of PRiMA in directing, and/or regulating the formation of G<sub>4</sub> enzyme. The PRiMA-linked G<sub>4</sub> BChE however has not been well studied, and therefore the expression profile of which in brain or muscle are not fully revealed.</p>
</sec>
<sec>
<title>ColQ-linked asymmetric forms of ChEs</title>
<p>Asymmetric forms of AChE and BChE are characterized by the presence of collagen-like tail, which is formed by the triple helical association of three ColQ subunits (Feng et al., <xref ref-type="bibr" rid="B20">1999</xref>). The cDNA encoding ColQ has been cloned in <italic>Torpedo</italic> (Krejci et al., <xref ref-type="bibr" rid="B28">1991</xref>), rat (Krejci et al., <xref ref-type="bibr" rid="B30">1997</xref>), human (Ohno et al., <xref ref-type="bibr" rid="B47">1998</xref>), quail, and chicken (Ruiz and Rotundo, <xref ref-type="bibr" rid="B54">2009a</xref>). The presence of the collagen-tailed forms of ChEs has been found in all classes of vertebrates, but not in invertebrates. They are specifically expressed in muscles and regulated by physiological activity (Sketelj and Brzin, <xref ref-type="bibr" rid="B58">1985</xref>; Deprez et al., <xref ref-type="bibr" rid="B14">2003</xref>; Lau et al., <xref ref-type="bibr" rid="B31">2008</xref>). In human and rat, <italic>COLQ</italic> gene has two transcripts, ColQ-1 and ColQ-1a: they are differentiatedly expressed in slow-twitch (ColQ-1) and fast-twitch (ColQ-1a) muscles (Ohno et al., <xref ref-type="bibr" rid="B47">1998</xref>; Krejci et al., <xref ref-type="bibr" rid="B29">1999</xref>). The differentiated expression patterns may account for the synaptic and non-synaptic expression profile of ColQ-linked AChE in fast slow-twitch and fast-twitch muscles, respectively (Lee et al., <xref ref-type="bibr" rid="B32">2004</xref>; Crne-Finderle et al., <xref ref-type="bibr" rid="B13">2005</xref>; Choi et al., <xref ref-type="bibr" rid="B12">2007</xref>).</p>
</sec>
<sec>
<title>Existence of AChE&#x02013;BChE hybrid ChEs</title>
<p>Most of our knowledge concerning ChEs derives from the studies on the classical AChE and BChE homogenous oligomers. However, the sequence similarity between AChE<sub>T</sub> and BChE<sub>T</sub> has been further emphasized regarding the existence of hybrid A<sub>12</sub> forms in new-born chicken muscle (Tsim et al., <xref ref-type="bibr" rid="B62">1988a</xref>), as well as a hybrid G<sub>4</sub> from in the brain (Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>) and embryonic muscles of chicken (Chen et al., <xref ref-type="bibr" rid="B11">2009</xref>). In these hybrid enzymes, both AChE<sub>T</sub> and BChE<sub>T</sub> are attached to the same anchoring protein, ColQ for A<sub>12</sub> form and PRiMA for G<sub>4</sub> form (Figure <xref ref-type="fig" rid="F1">1</xref>). The hybrid enzyme exists as a single type, with equivalent number of AChE and BChE catalytic subunits in a single molecule. Interestingly, the expression of these hybrid molecules in chicken brain and muscle was found to be developmentally regulated. In 1-day-old chicken muscle, the predominant form of AChE is A<sub>12</sub> hybrid form; however, the proportion of BChE subunits in the hybrid molecules progressively disappear during the muscle development from embryonic, hatching to adult, and the homogeneous asymmetric AChE becomes the sole form upon the muscle maturation (Tsim et al., <xref ref-type="bibr" rid="B63">1988b</xref>). On the other hand, a continuous increase of AChE&#x02013;BChE G<sub>4</sub> hybrid expression was observed in chicken brain, while an obvious decrease was found in the leg muscles. To date, we do not have conclusive idea about the underlining regulatory mechanism of these hybrid enzymes. We believe that AChE&#x02013;BChE hybrid enzymes could take part in cholinergic functions, which includes (i) they carry the catalytic activities of AChE and BChE in hydrolyzing ACh; (ii) they are associated with the anchoring protein, PRiMA or ColQ, which can anchor the hybrid enzymes onto the plasma membrane in the brain or nmj in the muscles; and (iii) the level of BChE<sub>T</sub> indirectly regulates the expression of homogenous G<sub>4</sub> AChE.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Two types of AChE&#x02013;BChE hybrid enzyme. (A)</bold> The PRiMA-linked G<sub>4</sub> AChE&#x02013;BChE hybrid in chicken brain. <bold>(B)</bold> The ColQ-linked A<sub>12</sub> AChE&#x02013;BChE hybrid in chicken muscle.</p></caption>
<graphic xlink:href="fnmol-04-00036-g001.tif"/>
</fig>
<p>In fact, the notion of having the existence of AChE&#x02013;BChE hybrid enzyme is not new. An abnormal ChE species in the serum of patients suffering from carcinomas was reported (Zakut et al., <xref ref-type="bibr" rid="B70">1988</xref>). This abnormal ChE species in human serum was inhibited by both AChE inhibitor BW284c51 and BChE inhibitor iso-OMPA. In addition, a collagen-tailed asymmetric hybrid AChE has been found relatively abundant in young chicken muscle (Tsim et al., <xref ref-type="bibr" rid="B63">1988b</xref>), but which tends to disappear at the adult stage (Tsim et al., <xref ref-type="bibr" rid="B63">1988b</xref>). Moreover, a hybrid tetramer having AChE and BChE activity was also found in cyst fluids derived from a human astrocytoma (Garc&#x000ED;a-Ayll&#x000F3;n et al., <xref ref-type="bibr" rid="B22">2001</xref>). However, none of the physiological function of these abnormal ChEs has been elucidated.</p>
</sec>
</sec>
<sec>
<title>Assembly Mechanism of AChE and BChE</title>
<p>The presence of G<sub>4</sub> and A<sub>12</sub> hybrid ChEs raised interesting questions about the organization of the subunits in a hybrid ChE complex. The assembly of AChE and BChE in cells could provide a good model in revealing the protein assembly of oligomers. By using DNA transfected cell cultures, the organization of different subunits in the PRiMA-linked ChE tetramers has been studied (Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>). Interestingly, AChE<sub>T</sub> and BChE<sub>T</sub> could not form hybrid dimer in the absence of anchoring protein; on the other hand, a single type of hybrid tetramer was clearly observed when the two catalytic subunits were co-expressed with PRiMA. Therefore, a &#x0201C;2&#x02009;&#x0002B;&#x02009;2&#x0201D; model is proposed for the organization of the four catalytic subunits in the PRiMA-linked ChE tetramers (Figure <xref ref-type="fig" rid="F2">2</xref>). After protein synthesis, AChE<sub>T</sub> and BChE<sub>T</sub> spontaneously form AChE homodimer and BChE<sub>T</sub> homodimer first. When two dimers (two AChE<sub>T</sub> dimers, or two BChE<sub>T</sub> dimers, or one AChE<sub>T</sub> dimer plus one BChE<sub>T</sub> dimer) encounter the anchoring protein, PRiMA, and thus ChE tetramers, e.g., G<sub>4</sub> AChE, G<sub>4</sub> BChE, and G<sub>4</sub> AChE/BChE hybrid, are formed.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Model for the assembly of PRiMA-linked AChE and BChE tetramers</bold>. When AChE<sub>T</sub> and BChE<sub>T</sub> subunits are expressed together, they form their own homodimers spontaneously. PRiMA recruits two homodimers together to form a PRiMA-linked tetramers, e.g., G<sub>4</sub> AChE, G<sub>4</sub> BChE. G<sub>4</sub> hybrid.</p></caption>
<graphic xlink:href="fnmol-04-00036-g002.tif"/>
</fig>
<sec>
<title>T-peptide is necessary for the oligomerization of AChE<sub>T</sub> and BChE<sub>T</sub></title>
<p>AChE<sub>T</sub> and BChE<sub>T</sub> have a catalytic domain of approximately 500 amino acids, followed by a C-terminal t-peptide of 40 and 41 residues, respectively. The t-peptide on AChE<sub>T</sub> and BChE<sub>T</sub> presents a considerable sequence similarity, with 24 identical residues, including seven aromatic residues and one cysteine near the C-terminus, which are conserved in human, cat, rabbit, mouse, cow, rat, chicken, and <italic>Torpedo</italic> (Massouli&#x000E9; et al., <xref ref-type="bibr" rid="B41">1993</xref>).</p>
<p>The t-peptide was reported to play an important role in the biosynthesis of ChEs, particularly in the protein folding and exportation. The presence of aromatic residues in the t-peptide induces the misfolding of newly synthesized AChE<sub>T</sub> polypeptides, and this effect depends on the hydrophobic character of these residues, because the same effect occurs when they are replaced by leucines (Falasca et al., <xref ref-type="bibr" rid="B19">2005</xref>). In the absence of a proline-rich attachment domain (PRAD)-containing anchoring protein, the t-peptide enhanced a pool of AChE<sub>T</sub> molecules toward endoplasmic reticulum (ER)-associated degradation (Belbeoc&#x02019;h et al., <xref ref-type="bibr" rid="B3">2003</xref>).</p>
<p>The major function of t-peptide is directing the assembly of tetramers of AChE<sub>T</sub> (Bon and Massouli&#x000E9;, <xref ref-type="bibr" rid="B7">1997</xref>) and BChE<sub>T</sub> (Blong et al., <xref ref-type="bibr" rid="B4">1997</xref>), as well as the association with the structure proteins, ColQ and PRiMA (Krejci et al., <xref ref-type="bibr" rid="B30">1997</xref>; Perrier et al., <xref ref-type="bibr" rid="B48">2002</xref>; Bon et al., <xref ref-type="bibr" rid="B6">2004</xref>). The t-peptide is also named as tryptophan (W) amphiphilic tetramerization (WAT) domains, which contains a sector with seven aromatic residues that are strictly conserved between AChE<sub>T</sub> and BChE<sub>T</sub>. The association between AChE<sub>T</sub> or BChE<sub>T</sub> catalytic subunits and anchoring proteins, ColQ and PRiMA, is mostly based on the interaction between four WAT domains on the t-peptides and a PRAD on ColQ or PRiMA (Bon et al., <xref ref-type="bibr" rid="B5">1997</xref>; Dvir et al., <xref ref-type="bibr" rid="B17">2004</xref>; Noureddine et al., <xref ref-type="bibr" rid="B46">2007</xref>). A crystallographic analysis of the complex of synthetic t-peptide and PRAD peptide indicated that four &#x003B1;-helical t-peptides form coiled-coil structure around the PRAD, which is arranged in a poly-proline II helix (Dvir et al., <xref ref-type="bibr" rid="B17">2004</xref>). In addition, the formation of disulfide bonds through the cysteine residues near the end of the t-peptides stabilizes the quaternary association, and in fact this association appears to be critical in the case of AChE dimer formation. Dimers could be hardly observed after mutagenesis of the C-terminal cysteine residues in H or T-peptides of <italic>Torpedo</italic> and rat AChE (Morel et al., <xref ref-type="bibr" rid="B45">2001</xref>; Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>).</p>
<p>The importance of t-peptide in the assembly of AChE<sub>T</sub> and BChE<sub>T</sub> was also reported by DNA mutagenesis studies. The truncated mutants, AChE<sub>&#x00394;T</sub> and BChE<sub>&#x00394;T</sub>, in which the t-peptides were deleted from the catalytic subunits, produced only monomers (Duval et al., <xref ref-type="bibr" rid="B15">1992</xref>). AChE<sub>T</sub> and AChE<sub>BChE-T</sub>, BChE<sub>T</sub> and BChE<sub>AChE-T</sub>, in which the catalytic domain of each enzyme was swapped with the t-peptide of each other, presented similar assembly ability to form oligomers (Liang et al., <xref ref-type="bibr" rid="B36">2009</xref>; Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>).</p>
</sec>
<sec>
<title>The FHB domain is involved in the selection of catalytic subunits during dimerization</title>
<p>Although the nature of AChE<sub>T</sub> and BChE<sub>T</sub> oligomers depends on the presence of the t-peptides, the catalytic domains also influence the oligomerization patterns. The X-ray crystallography studies of <italic>Torpedo</italic> AChE dimers showed that the contact zone between two AChE<sub>H</sub> subunits could be a &#x0201C;four-helix bundle&#x0201D; (FHB), formed by two &#x003B1; helices from each catalytic domain (Sussman et al., <xref ref-type="bibr" rid="B61">1991</xref>). In addition, rat AChE<sub>T</sub> was also demonstrated to dimerize through FHB inter-subunit contact zone (Morel et al., <xref ref-type="bibr" rid="B45">2001</xref>). Based on these findings, we compared the predicted FHB sequences that are responsible for the dimeric contact zone of AChE<sub>T</sub> and BChE<sub>T</sub> from different species. Indeed, FHB domains are highly conserved across different species for either AChE or BChE, including human, mouse, rat, chicken, and <italic>Torpedo</italic> (Figure <xref ref-type="fig" rid="F3">3</xref>). On the other hand, the similarity between FHB domains of AChE<sub>T</sub> and BChE<sub>T</sub> is very low. An inter-species hybrid dimer could be formed between human AChE<sub>T</sub> and chicken AChE<sub>T</sub>, but not between mammalian AChE<sub>T</sub> and BChE<sub>T</sub>, in transfected HEK293T cells (Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>). The selectivity of dimerization seems to be based on the feature that the FHB domains of AChE are highly conserved among different species of vertebrates, but are distinguished from vertebrate BChE<sub>T</sub>s. Moreover, another hybrid dimer, between human AChE<sub>BChE-T</sub> and chicken AChE<sub>T</sub>, which contained the similar FHB but different t-peptides, was formed when they were co-expressed together in HEK293T cultured cells (Chen et al., <xref ref-type="bibr" rid="B10">2010</xref>). This further confirmed that the catalytic domains, possibly the FHB domains, should play a critical role in the selection of subunits during the dimerization of ChEs.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Comparison of FHB sequences of AChE<sub>T</sub> and BChE<sub>T</sub> among different species</bold>. The sequences of the two alpha helices (FHB-1 and FHB-2) forming the dimeric contact zone of AChE and BChE are shown. The residues conserved across species are highlighted in bold. The amino acid sequences of human, mouse, rat, chicken, and <italic>Torpedo</italic> AChE catalytic subunits were deduced from nucleotide sequences accessed from GeneBank&#x02122; AAA68151, CAA39867, EDM13278, P36196, and CAA27169, respectively. The amino acid sequences of human, mouse, rat, and chicken BChE catalytic subunits were deduced from nucleotide sequences accessed from GeneBank&#x02122; AAA99296.1, AAH99977, NP_075231, and NP_989977, respectively.</p></caption>
<graphic xlink:href="fnmol-04-00036-g003.tif"/>
</fig>
<p>According to our current knowledge, the oligomerization of AChE<sub>T</sub> or BChE<sub>T</sub> with their associated anchoring proteins could rely on three types of interactions (Figure <xref ref-type="fig" rid="F4">4</xref>): (i) the FHB interaction for the formation of dimer through hydrophobic interaction; (ii) intercatenary disulfide bonds between the t-peptide of AChE<sub>T</sub> or BChE<sub>T</sub> subunits; and (iii) tight hydrophobic interaction between the WAT domains of AChE<sub>T</sub> or BChE<sub>T</sub> subunits and the PRAD on PRiMA or ColQ.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Three types of interaction involved in the oligomerization of AChE and BChE</bold>. <bold>(A)</bold> The FHB domains of AChE<sub>T</sub> or BChE<sub>T</sub> direct the dimer formation. <bold>(B)</bold> The t-peptides of AChE<sub>T</sub> or BChE<sub>T</sub> form intercatenary disulfide bonds. <bold>(C)</bold> WAT domains of AChE<sub>T</sub> and BChE<sub>T</sub> interact with PRAD on PRiMA or ColQ.</p></caption>
<graphic xlink:href="fnmol-04-00036-g004.tif"/>
</fig>
</sec>
<sec>
<title><italic>N</italic>-glycosylation is not required for the assembly of AChE<sub>T</sub> but is required for the membrane trafficking</title>
<p>AChE<sub>T</sub> and BChE<sub>T</sub> are well-known highly glycosylated enzymes, which carry various amounts of N-linked carbohydrate side chains attached to their core polypeptides (Liao et al., <xref ref-type="bibr" rid="B37">1992</xref>; Kolarich et al., <xref ref-type="bibr" rid="B27">2008</xref>). Mature human AChE<sub>T</sub> monomer possesses three potential N-linked glycosylation sites (Soreq et al., <xref ref-type="bibr" rid="B59">1990</xref>; Velan et al., <xref ref-type="bibr" rid="B64">1993</xref>). Mature human BChE<sub>T</sub> carries nine potential N-linked glycosylation sites (Lockridge et al., <xref ref-type="bibr" rid="B38">1987</xref>). These N-linked glycosylation sites, both in AChE and BChE, are highly conserved in mammals, which implies the physiological importance of these glycans for ChEs.</p>
<p>Glycosylation is proposed to be used as a marker for the progression of ChE forms through different subcellular compartments, since it is known that the glycans added in ER are remodeled and matured in Golgi apparatus. In chicken muscles, the assembly of catalytically active dimer and tetramer occurred in the rough ER, with a subset of tetramers being further assembled with ColQ in Golgi apparatus into asymmetric forms (Rotundo, <xref ref-type="bibr" rid="B51">1984</xref>). Once assembled, these catalytically active AChE oligomers were stable, acquired complex oligosaccharides in Golgi apparatus, and were transported to plasma membrane or secreted into medium (Rotundo, <xref ref-type="bibr" rid="B51">1984</xref>). All of these exported AChE molecules contain complex oligosaccharides, because they could bind to lectins such as wheat germ agglutinin and ricin, and were endoglycosidase H (Endo H) resistant (Rotundo et al., <xref ref-type="bibr" rid="B53">1989</xref>). In contrast, 70&#x02013;80% of the newly synthesized AChE polypeptide chains in chicken muscle appeared to be catalytically inactive and Endo H sensitive, and they were degraded intracellularly with a half-life of about 1.5&#x02009;h (Rotundo, <xref ref-type="bibr" rid="B52">1988</xref>). Recently, Ruiz and Rotundo (<xref ref-type="bibr" rid="B54">2009a</xref>,<xref ref-type="bibr" rid="B55">b</xref>) reported that the expression of AChE in quail muscles is regulated by muscle activity through post-translational controls: the over-expression of ER molecular chaperons, such as calnexin, ER protein 72, and protein disulfide isomerase results in an increase of catalytic active ColQ-linked AChE in quail muscles.</p>
<p>The biological function of the glycans on ChEs was elucidated by site mutagenesis studies. Elimination of <italic>N</italic>-glycosylation sites did not interfere with the ability of AChE<sub>T</sub> to form a soluble dimer (Velan et al., <xref ref-type="bibr" rid="B64">1993</xref>), or to assembly with PRiMA to form a PRiMA-linked AChE tetramer (Chen et al., <xref ref-type="bibr" rid="B9">2011</xref>). It appears therefore that the oligosaccharide side chains do not affect the structural elements that are responsible for the interaction of different subunits. Indeed, none of the <italic>N</italic>-glycosylation sites on AChE is close to or within the FHB domain implied in dimerization of AChE subunits (Sussman et al., <xref ref-type="bibr" rid="B61">1991</xref>; Morel et al., <xref ref-type="bibr" rid="B45">2001</xref>), or the t-peptide that allows the oligomerization of AChE<sub>T</sub> with the anchoring proteins, e.g., ColQ and PRiMA (Bon et al., <xref ref-type="bibr" rid="B6">2004</xref>). Moreover, the glycosylation of AChE<sub>T</sub> can greatly affects the protein folding and membrane trafficking. When the glycosylation is eliminated, the folding of AChE<sub>T</sub> fails, leading to a severe lost of the enzymatic activity (Chen et al., <xref ref-type="bibr" rid="B9">2011</xref>). In the absence of glycosylation, the secreted G<sub>1</sub> and G<sub>2</sub> AChE are dramatically reduced in transfected cells, and the PRiMA-linked G<sub>4</sub> AChE is retained in ER and fails to be exported to plasma membrane (Chen et al., <xref ref-type="bibr" rid="B9">2011</xref>).</p>
<p>The importance of <italic>N</italic>-glycosylation in the biosynthesis of AChE could explain the abnormality of glycosylation status in some pathological conditions. Proper glycosylation of AChE is important for normal brain function. Accumulation of molecular forms of AChE with altered patterns of glycosylation has been observed in the brain and cerebrospinal fluid of Alzheimer&#x02019;s patients (S&#x000E1;ez-Valero et al., <xref ref-type="bibr" rid="B57">1999</xref>, <xref ref-type="bibr" rid="B56">2000</xref>). Moreover, characteristics of AChE found in the senile plaques are different from those in normal brain with a higher degree of glycosylation, which is proposed to be one of the factors facilitating formation of amyloid fibrils in the senile plaques (Mimori et al., <xref ref-type="bibr" rid="B44">1997</xref>). These abnormalities in the glycosylation of AChE are very specific for Alzheimer&#x02019;s disease and are not detected in other dementia illness, which suggests that glycosylation of AChE may have a diagnostic value.</p>
<p>To summarize the assembly and membrane processing of G<sub>4</sub> ChEs, a model is being proposed as Figure <xref ref-type="fig" rid="F5">5</xref>. After the mRNAs are translated into peptides, AChE<sub>T</sub> and BChE<sub>T</sub> polypeptides undergo initial glycosylation, presumably in a co-translation manner. Shortly after the synthesis, the glycosylated AChE<sub>T</sub> and BChE<sub>T</sub> are assembled into homodimers spontaneously. When these homodimers encounter PRiMA, they form PRiMA-linked G<sub>4</sub> AChE, or G<sub>4</sub> BChE, or AChE&#x02013;BChE G<sub>4</sub> hybrid in ER. Afterward, PRiMA targets these G<sub>4</sub> complexes to Golgi apparatus where AChE<sub>T</sub> and BChE<sub>T</sub> subunits have further glycosylation. This trafficking allows the G<sub>4</sub> enzymes to be fully functional and finally become anchored onto the plasma membrane. During the whole process, the proper glycosylation of AChE<sub>T</sub> is the key point for the membrane targeting. Without glycosylation, AChE<sub>T</sub> polypeptides cannot fold properly, resulting in inactive AChE molecules. These un-glycosylated and inactive AChE<sub>T</sub> molecules can still form PRiMA-linked G<sub>4</sub> AChE and AChE&#x02013;BChE G<sub>4</sub> hybrid, but both of them are retained in ER, failing to be exported to Golgi apparatus, and finally they are subjected to degradation most possibly.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Proposed model for the assembly and membrane processing of G<sub>4</sub> ChEs</bold>. G<sub>4</sub> AChE, G<sub>4</sub> BChE, and AChE&#x02013;BChE G<sub>4</sub> hybrid molecules are assembled in ER where both AChE<sub>T</sub> and BChE<sub>T</sub> subunits have initial glycosylation. These G<sub>4</sub> complexes are subsequently transported to Golgi apparatus where the catalytic subunits can have further glycosylation, and finally anchored onto the plasma membrane. The AChE<sub>T</sub> glycosylation mutant, in which the glycosylation is completely abolished, is still able to assembly with PRiMA and BChE<sub>T</sub> to form G<sub>4</sub> AChE and G<sub>4</sub> hybrid. However, both of them are retained in ER, which possibly will be subjected to the degradation pathway.</p></caption>
<graphic xlink:href="fnmol-04-00036-g005.tif"/>
</fig>
</sec>
</sec>
<sec>
<title>Summary</title>
<p>The assembly of ChEs constitutes a fascinating model to study numerous biological processes, such as post-translational modification, protein&#x02013;protein interactions, membrane trafficking, and protein degradation. The physiological function of ChEs depends on the catalytic property of the enzymes and the restricted subcellular localization. In brain and muscles, ChEs display extremely rich molecular polymorphisms, possessing soluble, membrane-bound and basal lamina-anchored forms, and additionally, hybrid ChEs containing both AChE and BChE catalytic subunits also curiously exist. During the assembly of these ChE complexes, dimer is believed to be the precursor for the PRiMA-linked tetramers and ColQ-linked asymmetric forms. The dimer formation of AChE or BChE depends on recognition between the FHB domains in their catalytic domains, and the assembly of tetramers with PRiMA or ColQ requires the interaction of WAT domain on the C-terminal t-peptides with the PRAD domain on PRiMA or ColQ. N-linked glycans of AChE are employed as both maturation and quality control tags that dictate the destination of the enzyme being exported or not, which inspires that the control of glycosylation may be as a means in regulating the level of functional AChE in pathological conditions. However, there are still several questions out there, which have not been resolved. These questions are: (i) the possible control mechanism in directing the formation of different forms of ChEs; (ii) the regulatory mechanism for the protein trafficking of different states of ChEs; (iii) the fate of the active and inactive ChEs; and (iv) the possible non-cholinergic function of different forms of ChEs.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This research in Tsim&#x02019;s laboratory was supported by grants from the Research Grants Council of Hong Kong (662407, 660409, 662911, F-HK21/06T) and the Croucher Foundation (CAS-CF07/08.SC03). The authors are grateful to Drs. Jean Massouli&#x000E9; and Suzanne Bon from Institut de Biologie de l&#x02019;Ecole Normale Sup&#x000E9;rieure, Paris, France for their advices during the study.</p>
</ack>
<sec>
<title>Abbreviations</title>
<p>A, asymmetric; ACh, acetylcholine; AChE, acetylcholinesterase; BChE, butyrylcholinesterase; ChEs, cholinesterases; ColQ, collagen tail; Endo H, endoglycosidase H; ER, endoplasmic reticulum; FHB, four-helix bundle; G<sub>4</sub>, tetrameric globular form; nmj, neuromuscular junction; PRAD, proline-rich attachment domain; PRiMA, proline-rich membrane anchor; WAT, tryptophan amphiphilic tetramerization.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname> <given-names>L.</given-names></name> <name><surname>Berry</surname> <given-names>W. K.</given-names></name></person-group> (<year>1953</year>). <article-title>Two selective inhibitors of cholinesterase</article-title>. <source>Biochem. J.</source> <volume>54</volume>, <fpage>695</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">13058976</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajgar</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment</article-title>. <source>Adv. Clin. Chem.</source> <volume>38</volume>, <fpage>151</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="doi">10.1016/S0065-2423(04)38006-6</pub-id><pub-id pub-id-type="pmid">15521192</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belbeoc&#x02019;h</surname> <given-names>S.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>The C-terminal t peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway</article-title>. <source>EMBO J.</source> <volume>22</volume>, <fpage>3536</fpage>&#x02013;<lpage>3545</lpage>.<pub-id pub-id-type="doi">10.1093/emboj/cdg360</pub-id><pub-id pub-id-type="pmid">12853469</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blong</surname> <given-names>R. M.</given-names></name> <name><surname>Bedows</surname> <given-names>E.</given-names></name> <name><surname>Lockridge</surname> <given-names>O.</given-names></name></person-group> (<year>1997</year>). <article-title>Tetramerization domain of human butyrylcholinesterase is at the C-terminus</article-title>. <source>Biochem. J.</source> <volume>327</volume>, <fpage>747</fpage>&#x02013;<lpage>757</lpage>.<pub-id pub-id-type="pmid">9581552</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Coussen</surname> <given-names>F.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail</article-title>. <source>J. Biol. Chem.</source> <volume>272</volume>, <fpage>3016</fpage>&#x02013;<lpage>3021</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.272.5.3016</pub-id><pub-id pub-id-type="pmid">9006950</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Dufourcq</surname> <given-names>J.</given-names></name> <name><surname>Leroy</surname> <given-names>J.</given-names></name> <name><surname>Cornut</surname> <given-names>I.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>The C-terminal t peptide of acetylcholinesterase forms an alpha helix that supports homomeric and heteromeric interactions</article-title>. <source>Eur. J. Biochem.</source> <volume>271</volume>, <fpage>33</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1046/j.1432-1033.2003.03892.x</pub-id><pub-id pub-id-type="pmid">14686917</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>Quaternary associations of acetylcholinesterase. I. Oligomeric associations of T subunits with and without the amino-terminal domain of the collagen tail</article-title>. <source>J. Biol. Chem.</source> <volume>272</volume>, <fpage>3007</fpage>&#x02013;<lpage>3015</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.272.5.3007</pub-id><pub-id pub-id-type="pmid">9006949</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname> <given-names>T.</given-names></name> <name><surname>Nizri</surname> <given-names>E.</given-names></name> <name><surname>Irony-Tur-Sinai</surname> <given-names>M.</given-names></name> <name><surname>Hamra-Amitay</surname> <given-names>Y.</given-names></name> <name><surname>Wirguin</surname> <given-names>I.</given-names></name></person-group> (<year>2008</year>). <article-title>Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation</article-title>. <source>J. Neuroimmunol.</source> <fpage>201</fpage>&#x02013;<lpage>202</lpage>, 121&#x02013;127.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.05.022</pub-id><pub-id pub-id-type="pmid">18684515</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Chan</surname> <given-names>W. K.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Guo</surname> <given-names>A. J.</given-names></name> <name><surname>Chan</surname> <given-names>G. K.</given-names></name> <name><surname>Luk</surname> <given-names>W. K.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2011</year>). <article-title>The assembly of PRiMA-linked acetylcholinesterase: glycosylation is required for enzymatic activity but not for oligomerization</article-title>. <source>J Biol Chem.</source> <volume>286</volume>, <fpage>32948</fpage>&#x02013;<lpage>32961</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M110.175273</pub-id><pub-id pub-id-type="pmid">21795704</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Chan</surname> <given-names>W. K.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Chan</surname> <given-names>G. K.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2010</year>). <article-title>The PRiMA-linked cholinesterase tetramers are assembled from homodimers: hybrid molecules composed of acetylcholinesterase and butyrylcholinesterase dimers are up-regulated during development of chicken brain</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume>, <fpage>27265</fpage>&#x02013;<lpage>27278</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M110.101469</pub-id><pub-id pub-id-type="pmid">20566626</pub-id></citation></ref>
<ref id="B11"><citation citation-type="confproc"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2009</year>). <article-title>&#x0201C;The molecular assembly of acetylcholinesterase and butyrylcholinesterase: the formation of PRiMA-linked G4 hybrid,&#x0201D;</article-title> in <conf-name>Joint Scientific Meeting of the 27th Hong Kong Society of Neurosciences and the 6th Biophysical Society of Hong Kong</conf-name>, <conf-loc>Hong Kong</conf-loc>, <fpage>144</fpage>.</citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Ting</surname> <given-names>A. K.</given-names></name> <name><surname>Lau</surname> <given-names>F. T.</given-names></name> <name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Siow</surname> <given-names>N. L.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Calcitonin gene-related peptide induces the expression of acetylcholinesterase-associated collagen ColQ in muscle: a distinction in driving two different promoters between fast- and slow-twitch muscle fibers</article-title>. <source>J. Neurochem.</source> <volume>102</volume>, <fpage>1316</fpage>&#x02013;<lpage>1328</lpage>.<pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04630.x</pub-id><pub-id pub-id-type="pmid">17488278</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crne-Finderle</surname> <given-names>N.</given-names></name> <name><surname>Pregelj</surname> <given-names>P.</given-names></name> <name><surname>Sketelj</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Junctional and extrajunctional acetylcholinesterase in skeletal muscle fibers</article-title>. <source>Chem. Biol. Interact.</source> <fpage>157</fpage>&#x02013;<lpage>158</lpage>, 23&#x02013;27.<pub-id pub-id-type="doi">10.1016/j.cbi.2005.10.008</pub-id><pub-id pub-id-type="pmid">16303120</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deprez</surname> <given-names>P.</given-names></name> <name><surname>Inestrosa</surname> <given-names>N. C.</given-names></name> <name><surname>Krejci</surname> <given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase</article-title>. <source>J. Biol. Chem.</source> <volume>278</volume>, <fpage>23233</fpage>&#x02013;<lpage>23242</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M301384200</pub-id><pub-id pub-id-type="pmid">12684510</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duval</surname> <given-names>N.</given-names></name> <name><surname>Krejci</surname> <given-names>E.</given-names></name> <name><surname>Grassi</surname> <given-names>J.</given-names></name> <name><surname>Coussen</surname> <given-names>F.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name></person-group> (<year>1992</year>). <article-title>Molecular architecture of acetylcholinesterase collagen-tailed forms; construction of a glycolipid-tailed tetramer</article-title>. <source>EMBO J.</source> <volume>11</volume>, <fpage>3255</fpage>&#x02013;<lpage>3261</lpage>.<pub-id pub-id-type="pmid">1380451</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duysen</surname> <given-names>E. G.</given-names></name> <name><surname>Li</surname> <given-names>B.</given-names></name> <name><surname>Xie</surname> <given-names>W.</given-names></name> <name><surname>Schopfer</surname> <given-names>L. M.</given-names></name> <name><surname>Anderson</surname> <given-names>R. S.</given-names></name> <name><surname>Broomfield</surname> <given-names>C. A.</given-names></name> <name><surname>Lockridge</surname> <given-names>O.</given-names></name></person-group> (<year>2001</year>). <article-title>Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>299</volume>, <fpage>528</fpage>&#x02013;<lpage>535</lpage>.<pub-id pub-id-type="pmid">11602663</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dvir</surname> <given-names>H.</given-names></name> <name><surname>Harel</surname> <given-names>M.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Liu</surname> <given-names>W. Q.</given-names></name> <name><surname>Vidal</surname> <given-names>M.</given-names></name> <name><surname>Garbay</surname> <given-names>C.</given-names></name> <name><surname>Sussman</surname> <given-names>J. L.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Silman</surname> <given-names>I.</given-names></name></person-group> (<year>2004</year>). <article-title>The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix</article-title>. <source>EMBO J.</source> <volume>23</volume>, <fpage>4394</fpage>&#x02013;<lpage>4405</lpage>.<pub-id pub-id-type="doi">10.1038/sj.emboj.7600425</pub-id><pub-id pub-id-type="pmid">15526038</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emre</surname> <given-names>M.</given-names></name> <name><surname>Aarsland</surname> <given-names>D.</given-names></name> <name><surname>Albanese</surname> <given-names>A.</given-names></name> <name><surname>Byrne</surname> <given-names>E. J.</given-names></name> <name><surname>Deuschl</surname> <given-names>G.</given-names></name> <name><surname>De Deyn</surname> <given-names>P. P.</given-names></name> <name><surname>Durif</surname> <given-names>F.</given-names></name> <name><surname>Kulisevsky</surname> <given-names>J.</given-names></name> <name><surname>van Laar</surname> <given-names>T.</given-names></name> <name><surname>Lees</surname> <given-names>A.</given-names></name> <name><surname>Poewe</surname> <given-names>W.</given-names></name> <name><surname>Robillard</surname> <given-names>A.</given-names></name> <name><surname>Rosa</surname> <given-names>M. M.</given-names></name> <name><surname>Wolters</surname> <given-names>E.</given-names></name> <name><surname>Quarg</surname> <given-names>P.</given-names></name> <name><surname>Tekin</surname> <given-names>S.</given-names></name> <name><surname>Lane</surname> <given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Rivastigmine for dementia associated with Parkinson&#x02019;s disease</article-title>. <source>N. Engl. J. Med.</source> <volume>351</volume>, <fpage>2509</fpage>&#x02013;<lpage>2518</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa041470</pub-id><pub-id pub-id-type="pmid">15590953</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falasca</surname> <given-names>C.</given-names></name> <name><surname>Perrier</surname> <given-names>N.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Determinants of the t peptide involved in folding, degradation, and secretion of acetylcholinesterase</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume>, <fpage>878</fpage>&#x02013;<lpage>886</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M409201200</pub-id><pub-id pub-id-type="pmid">15452125</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>G.</given-names></name> <name><surname>Krejci</surname> <given-names>E.</given-names></name> <name><surname>Molgo</surname> <given-names>J.</given-names></name> <name><surname>Cunningham</surname> <given-names>J. M.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Sanes</surname> <given-names>J. R.</given-names></name></person-group> (<year>1999</year>). <article-title>Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function</article-title>. <source>J. Cell Biol.</source> <volume>144</volume>, <fpage>1349</fpage>&#x02013;<lpage>1360</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.144.6.1349</pub-id><pub-id pub-id-type="pmid">10087275</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feyereisen</surname> <given-names>R.</given-names></name></person-group> (<year>1995</year>). <article-title>Molecular biology of insecticide resistance</article-title>. <source>Toxicol. Lett.</source> <fpage>82</fpage>&#x02013;<lpage>83</lpage>, 83&#x02013;90.<pub-id pub-id-type="doi">10.1016/0378-4274(95)03470-6</pub-id><pub-id pub-id-type="pmid">8597150</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ED;a-Ayll&#x000F3;n</surname> <given-names>M. S.</given-names></name> <name><surname>S&#x000E1;ez-Valero</surname> <given-names>J.</given-names></name> <name><surname>Mu&#x000F1;oz-Delgado</surname> <given-names>E.</given-names></name> <name><surname>Vidal</surname> <given-names>C. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma</article-title>. <source>Neuroscience</source> <volume>107</volume>, <fpage>199</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="doi">10.1016/S0306-4522(01)00355-4</pub-id><pub-id pub-id-type="pmid">11731094</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giacobini</surname> <given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>Cholinesterase inhibitors stabilize Alzheimer&#x02019;s disease</article-title>. <source>Neurochem. Res.</source> <volume>25</volume>, <fpage>1185</fpage>&#x02013;<lpage>1190</lpage>.<pub-id pub-id-type="doi">10.1023/A:1007679709322</pub-id><pub-id pub-id-type="pmid">11059792</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname> <given-names>M.</given-names></name> <name><surname>Fazzini</surname> <given-names>E.</given-names></name></person-group> (<year>1996</year>). <article-title>Cholinesterase inhibition in Parkinson&#x02019;s disease</article-title>. <source>J. Neurol. Neurosurg. Psychiatr.</source> <volume>61</volume>, <fpage>324</fpage>&#x02013;<lpage>325</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.61.3.324-a</pub-id><pub-id pub-id-type="pmid">8795611</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inestrosa</surname> <given-names>N. C.</given-names></name> <name><surname>Moreno</surname> <given-names>R. D.</given-names></name> <name><surname>Fuentes</surname> <given-names>M. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Monomeric amphiphilic forms of acetylcholinesterase appear early during brain development and may correspond to biosynthetic precursors of the amphiphilic G4 forms</article-title>. <source>Neurosci. Lett.</source> <volume>173</volume>, <fpage>155</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="doi">10.1016/0304-3940(94)90172-4</pub-id><pub-id pub-id-type="pmid">7936404</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufer</surname> <given-names>D.</given-names></name> <name><surname>Friedman</surname> <given-names>A.</given-names></name> <name><surname>Seidman</surname> <given-names>S.</given-names></name> <name><surname>Soreq</surname> <given-names>H.</given-names></name></person-group> (<year>1998</year>). <article-title>Acute stress facilitates long-lasting changes in cholinergic gene expression</article-title>. <source>Nature</source> <volume>393</volume>, <fpage>373</fpage>&#x02013;<lpage>377</lpage>.<pub-id pub-id-type="doi">10.1038/30741</pub-id><pub-id pub-id-type="pmid">9620801</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolarich</surname> <given-names>D.</given-names></name> <name><surname>Weber</surname> <given-names>A.</given-names></name> <name><surname>Pabst</surname> <given-names>M.</given-names></name> <name><surname>Stadlmann</surname> <given-names>J.</given-names></name> <name><surname>Teschner</surname> <given-names>W.</given-names></name> <name><surname>Ehrlich</surname> <given-names>H.</given-names></name> <name><surname>Schwarz</surname> <given-names>H. P.</given-names></name> <name><surname>Altmann</surname> <given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Glycoproteomic characterization of butyrylcholinesterase from human plasma</article-title>. <source>Proteomics</source> <volume>8</volume>, <fpage>254</fpage>&#x02013;<lpage>263</lpage>.<pub-id pub-id-type="doi">10.1002/pmic.200700720</pub-id><pub-id pub-id-type="pmid">18203274</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krejci</surname> <given-names>E.</given-names></name> <name><surname>Coussen</surname> <given-names>F.</given-names></name> <name><surname>Duval</surname> <given-names>N.</given-names></name> <name><surname>Chatel</surname> <given-names>J. M.</given-names></name> <name><surname>Legay</surname> <given-names>C.</given-names></name> <name><surname>Puype</surname> <given-names>M.</given-names></name> <name><surname>Vandekerckhove</surname> <given-names>J.</given-names></name> <name><surname>Cartaud</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>1991</year>). <article-title>Primary structure of a collagenic tail peptide of <italic>Torpedo</italic> acetylcholinesterase: co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells</article-title>. <source>EMBO J.</source> <volume>10</volume>, <fpage>1285</fpage>&#x02013;<lpage>1293</lpage>.<pub-id pub-id-type="pmid">1840520</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krejci</surname> <given-names>E.</given-names></name> <name><surname>Legay</surname> <given-names>C.</given-names></name> <name><surname>Thomine</surname> <given-names>S.</given-names></name> <name><surname>Sketelj</surname> <given-names>J.</given-names></name> <name><surname>Massoulie</surname> <given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>Differences in expression of acetylcholinesterase and collagen Q control the distribution and oligomerization of the collagen-tailed forms in fast and slow muscles</article-title>. <source>J. Neurosci.</source> <volume>19</volume>, <fpage>10672</fpage>&#x02013;<lpage>10679</lpage>.<pub-id pub-id-type="pmid">10594051</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krejci</surname> <given-names>E.</given-names></name> <name><surname>Thomine</surname> <given-names>S.</given-names></name> <name><surname>Boschetti</surname> <given-names>N.</given-names></name> <name><surname>Legay</surname> <given-names>C.</given-names></name> <name><surname>Sketelj</surname> <given-names>J.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>The mammalian gene of acetylcholinesterase-associated collagen</article-title>. <source>J. Biol. Chem.</source> <volume>272</volume>, <fpage>22840</fpage>&#x02013;<lpage>22847</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.272.36.22840</pub-id><pub-id pub-id-type="pmid">9278446</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>F. T.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Zhu</surname> <given-names>J. T.</given-names></name> <name><surname>Bi</surname> <given-names>C. W.</given-names></name> <name><surname>Chu</surname> <given-names>G. K.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Myocyte enhancer factor 2 mediates acetylcholine-induced expression of acetylcholinesterase-associated collagen ColQ in cultured myotubes</article-title>. <source>Mol. Cell. Neurosci.</source> <volume>39</volume>, <fpage>429</fpage>&#x02013;<lpage>438</lpage>.<pub-id pub-id-type="doi">10.1016/j.mcn.2008.07.018</pub-id><pub-id pub-id-type="pmid">18718538</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>H. H.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Ting</surname> <given-names>A. K.</given-names></name> <name><surname>Siow</surname> <given-names>N. L.</given-names></name> <name><surname>Jiang</surname> <given-names>J. X.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Transcriptional regulation of acetylcholinesterase-associated collagen ColQ</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <fpage>27098</fpage>&#x02013;<lpage>27107</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M405271200</pub-id><pub-id pub-id-type="pmid">15102835</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Legay</surname> <given-names>C.</given-names></name> <name><surname>Huchet</surname> <given-names>M.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Changeux</surname> <given-names>J.</given-names></name></person-group> (<year>1995</year>). <article-title>Developmental regulation of acetylcholinesterase transcripts in the mouse diaphragm: alternative splicing and focalization</article-title>. <source>Eur. J. Neurosci.</source> <volume>7</volume>, <fpage>1803</fpage>&#x02013;<lpage>1809</lpage>.<pub-id pub-id-type="doi">10.1111/j.1460-9568.1995.tb00699.x</pub-id><pub-id pub-id-type="pmid">7582132</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Mok</surname> <given-names>M. K.</given-names></name> <name><surname>Chu</surname> <given-names>G. K.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Restricted localization of proline-rich membrane anchor (PRiMA) of globular form acetylcholinesterase at the neuromuscular junctions &#x02013; contribution and expression from motor neurons</article-title>. <source>FEBS J.</source> <volume>276</volume>, <fpage>3031</fpage>&#x02013;<lpage>3042</lpage>.<pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07022.x</pub-id><pub-id pub-id-type="pmid">19490106</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Camp</surname> <given-names>S.</given-names></name> <name><surname>Rachinsky</surname> <given-names>T. L.</given-names></name> <name><surname>Getman</surname> <given-names>D.</given-names></name> <name><surname>Taylor</surname> <given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression</article-title>. <source>J. Biol. Chem.</source> <volume>266</volume>, <fpage>23083</fpage>&#x02013;<lpage>23090</lpage>.<pub-id pub-id-type="pmid">1744105</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>D.</given-names></name> <name><surname>Blouet</surname> <given-names>J. P.</given-names></name> <name><surname>Borrega</surname> <given-names>F.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase</article-title>. <source>FEBS J.</source> <volume>276</volume>, <fpage>94</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="doi">10.1111/j.1742-4658.2008.06756.x</pub-id><pub-id pub-id-type="pmid">19019080</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>J.</given-names></name> <name><surname>Heider</surname> <given-names>H.</given-names></name> <name><surname>Sun</surname> <given-names>M. C.</given-names></name> <name><surname>Brodbeck</surname> <given-names>U.</given-names></name></person-group> (<year>1992</year>). <article-title>Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes</article-title>. <source>J. Neurochem.</source> <volume>58</volume>, <fpage>1230</fpage>&#x02013;<lpage>1238</lpage>.<pub-id pub-id-type="doi">10.1111/j.1471-4159.1992.tb11333.x</pub-id><pub-id pub-id-type="pmid">1548461</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lockridge</surname> <given-names>O.</given-names></name> <name><surname>Bartels</surname> <given-names>C. F.</given-names></name> <name><surname>Vaughan</surname> <given-names>T. A.</given-names></name> <name><surname>Wong</surname> <given-names>C. K.</given-names></name> <name><surname>Norton</surname> <given-names>S. E.</given-names></name> <name><surname>Johnson</surname> <given-names>L. L.</given-names></name></person-group> (<year>1987</year>). <article-title>Complete amino acid sequence of human serum cholinesterase</article-title>. <source>J. Biol. Chem.</source> <volume>262</volume>, <fpage>549</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">3542989</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>The origin of the molecular diversity and functional anchoring of cholinesterases</article-title>. <source>Neurosignals</source> <volume>11</volume>, <fpage>130</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="doi">10.1159/000065054</pub-id><pub-id pub-id-type="pmid">12138250</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Perrier</surname> <given-names>N.</given-names></name> <name><surname>Falasca</surname> <given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring</article-title>. <source>Chem. Biol. Interact.</source> <fpage>157</fpage>&#x02013;<lpage>158</lpage>, 3&#x02013;14.<pub-id pub-id-type="doi">10.1016/j.cbi.2005.10.002</pub-id><pub-id pub-id-type="pmid">16257397</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Pezzementi</surname> <given-names>L.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Krejci</surname> <given-names>E.</given-names></name> <name><surname>Vallette</surname> <given-names>F. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Molecular and cellular biology of cholinesterases</article-title>. <source>Prog. Neurobiol.</source> <volume>41</volume>, <fpage>31</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/0301-0082(93)90040-Y</pub-id><pub-id pub-id-type="pmid">8321908</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehndiratta</surname> <given-names>M. M.</given-names></name> <name><surname>Pandey</surname> <given-names>S.</given-names></name> <name><surname>Kuntzer</surname> <given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Acetylcholinesterase inhibitor treatment for myasthenia gravis</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>2</volume>, <fpage>CD006986</fpage>.<pub-id pub-id-type="pmid">21328290</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendel</surname> <given-names>B.</given-names></name> <name><surname>Rudney</surname> <given-names>H.</given-names></name></person-group> (<year>1943</year>). <article-title>Studies on cholinesterase: 1. Cholinesterase and pseudo-cholinesterase</article-title>. <source>Biochem. J.</source> <volume>37</volume>, <fpage>59</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">16747599</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mimori</surname> <given-names>Y.</given-names></name> <name><surname>Nakamura</surname> <given-names>S.</given-names></name> <name><surname>Yukawa</surname> <given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Abnormalities of acetylcholinesterase in Alzheimer&#x02019;s disease with special reference to effect of acetylcholinesterase inhibitor</article-title>. <source>Behav. Brain Res.</source> <volume>83</volume>, <fpage>25</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/S0166-4328(97)86041-X</pub-id><pub-id pub-id-type="pmid">9062656</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morel</surname> <given-names>N.</given-names></name> <name><surname>Leroy</surname> <given-names>J.</given-names></name> <name><surname>Ayon</surname> <given-names>A.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Acetylcholinesterase H and T dimers are associated through the same contact. Mutations at this interface interfere with the C-terminal T peptide, inducing degradation rather than secretion</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>37379</fpage>&#x02013;<lpage>37389</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M103574200</pub-id><pub-id pub-id-type="pmid">11443120</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noureddine</surname> <given-names>H.</given-names></name> <name><surname>Schmitt</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name> <name><surname>Garbay</surname> <given-names>C.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Assembly of acetylcholinesterase tetramers by peptidic motifs from the proline-rich membrane anchor, PRiMA: competition between degradation and secretion pathways of heteromeric complexes</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume>, <fpage>3487</fpage>&#x02013;<lpage>3497</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M607221200</pub-id><pub-id pub-id-type="pmid">17158452</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname> <given-names>K.</given-names></name> <name><surname>Brengman</surname> <given-names>J.</given-names></name> <name><surname>Tsujino</surname> <given-names>A.</given-names></name> <name><surname>Engel</surname> <given-names>A. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>95</volume>, <fpage>9654</fpage>&#x02013;<lpage>9659</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.95.16.9654</pub-id><pub-id pub-id-type="pmid">9689136</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrier</surname> <given-names>A. L.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Krejci</surname> <given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>PRiMA: the membrane anchor of acetylcholinesterase in the brain</article-title>. <source>Neuron</source> <volume>33</volume>, <fpage>275</fpage>&#x02013;<lpage>285</lpage>.<pub-id pub-id-type="doi">10.1016/S0896-6273(01)00584-0</pub-id><pub-id pub-id-type="pmid">11804574</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrier</surname> <given-names>N. A.</given-names></name> <name><surname>Kh&#x000E9;rif</surname> <given-names>S.</given-names></name> <name><surname>Perrier</surname> <given-names>A. L.</given-names></name> <name><surname>Dumas</surname> <given-names>S.</given-names></name> <name><surname>Mallet</surname> <given-names>J.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Expression of PRiMA in the mouse brain: membrane anchoring and accumulation of &#x0201C;tailed&#x0201D; acetylcholinesterase</article-title>. <source>Eur. J. Neurosci.</source> <volume>18</volume>, <fpage>1837</fpage>&#x02013;<lpage>1847</lpage>.<pub-id pub-id-type="doi">10.1046/j.1460-9568.2003.02914.x</pub-id><pub-id pub-id-type="pmid">14622217</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrier</surname> <given-names>N. A.</given-names></name> <name><surname>Salani</surname> <given-names>M.</given-names></name> <name><surname>Falasca</surname> <given-names>C.</given-names></name> <name><surname>Bon</surname> <given-names>S.</given-names></name> <name><surname>Augusti-Tocco</surname> <given-names>G.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo</article-title>. <source>J. Neurochem.</source> <volume>94</volume>, <fpage>629</fpage>&#x02013;<lpage>638</lpage>.<pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03140.x</pub-id><pub-id pub-id-type="pmid">16001972</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotundo</surname> <given-names>R. L.</given-names></name></person-group> (<year>1984</year>). <article-title>Asymmetric acetylcholinesterase is assembled in the Golgi apparatus</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>81</volume>, <fpage>479</fpage>&#x02013;<lpage>483</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.81.2.479</pub-id><pub-id pub-id-type="pmid">6582503</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotundo</surname> <given-names>R. L.</given-names></name></person-group> (<year>1988</year>). <article-title>Biogenesis of acetylcholinesterase molecular forms in muscle. Evidence for a rapidly turning over, catalytically inactive precursor pool</article-title>. <source>J. Biol. Chem.</source> <volume>263</volume>, <fpage>19398</fpage>&#x02013;<lpage>19406</lpage>.<pub-id pub-id-type="pmid">3198632</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotundo</surname> <given-names>R. L.</given-names></name> <name><surname>Thomas</surname> <given-names>K.</given-names></name> <name><surname>Porter-Jordan</surname> <given-names>K.</given-names></name> <name><surname>Benson</surname> <given-names>R. J.</given-names></name> <name><surname>Fernandez-Valle</surname> <given-names>C.</given-names></name> <name><surname>Fine</surname> <given-names>R. E.</given-names></name></person-group> (<year>1989</year>). <article-title>Intracellular transport, sorting, and turnover of acetylcholinesterase. Evidence for an endoglycosidase H-sensitive form in Golgi apparatus, sarcoplasmic reticulum, and clathrin-coated vesicles and its rapid degradation by a non-lysosomal mechanism</article-title>. <source>J. Biol. Chem.</source> <volume>264</volume>, <fpage>3146</fpage>&#x02013;<lpage>3152</lpage>.<pub-id pub-id-type="pmid">2563379</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname> <given-names>C. A.</given-names></name> <name><surname>Rotundo</surname> <given-names>R. L.</given-names></name></person-group> (<year>2009a</year>). <article-title>Dissociation of transcription, translation, and assembly of collagen tailed acetylcholinesterase in skeletal muscle</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>21488</fpage>&#x02013;<lpage>21495</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M109.038471</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname> <given-names>C. A.</given-names></name> <name><surname>Rotundo</surname> <given-names>R. L.</given-names></name></person-group> (<year>2009b</year>). <article-title>Limiting role of protein disulfide isomerase in the expression of collagen-tailed acetylcholinesterase forms in muscle</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>31753</fpage>&#x02013;<lpage>31763</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M109.038471</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000E1;ez-Valero</surname> <given-names>J.</given-names></name> <name><surname>Barquero</surname> <given-names>M. S.</given-names></name> <name><surname>Marcos</surname> <given-names>A.</given-names></name> <name><surname>McLean</surname> <given-names>C. A.</given-names></name> <name><surname>Small</surname> <given-names>D. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer&#x02019;s disease</article-title>. <source>J. Neurol. Neurosurg. Psychiatr.</source> <volume>69</volume>, <fpage>664</fpage>&#x02013;<lpage>667</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.69.5.664</pub-id><pub-id pub-id-type="pmid">11032625</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000E1;ez-Valero</surname> <given-names>J.</given-names></name> <name><surname>Sberna</surname> <given-names>G.</given-names></name> <name><surname>McLean</surname> <given-names>C. A.</given-names></name> <name><surname>Small</surname> <given-names>D. H.</given-names></name></person-group> (<year>1999</year>). <article-title>Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer&#x02019;s disease</article-title>. <source>J. Neurochem.</source> <volume>72</volume>, <fpage>1600</fpage>&#x02013;<lpage>1608</lpage>.<pub-id pub-id-type="doi">10.1046/j.1471-4159.1999.721600.x</pub-id><pub-id pub-id-type="pmid">10098867</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sketelj</surname> <given-names>J.</given-names></name> <name><surname>Brzin</surname> <given-names>M.</given-names></name></person-group> (<year>1985</year>). <article-title>Asymmetric molecular forms of acetylcholinesterase in mammalian skeletal muscles</article-title>. <source>J. Neurosci. Res.</source> <volume>14</volume>, <fpage>95</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1002/jnr.490140109</pub-id><pub-id pub-id-type="pmid">4020901</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soreq</surname> <given-names>H.</given-names></name> <name><surname>Ben-Aziz</surname> <given-names>R.</given-names></name> <name><surname>Prody</surname> <given-names>C. A.</given-names></name> <name><surname>Seidman</surname> <given-names>S.</given-names></name> <name><surname>Gnatt</surname> <given-names>A.</given-names></name> <name><surname>Neville</surname> <given-names>L.</given-names></name> <name><surname>Lieman-Hurwitz</surname> <given-names>J.</given-names></name> <name><surname>Lev-Lehman</surname> <given-names>E.</given-names></name> <name><surname>Ginzberg</surname> <given-names>D.</given-names></name> <name><surname>Lipidot-Lifson</surname> <given-names>Y.</given-names></name> <name><surname>Zakut</surname> <given-names>H.</given-names></name></person-group> (<year>1990</year>). <article-title>Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G&#x02009;&#x0002B;&#x02009;C-rich attenuating structure</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>87</volume>, <fpage>9688</fpage>&#x02013;<lpage>9692</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.87.24.9688</pub-id><pub-id pub-id-type="pmid">2263619</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname> <given-names>J. G.</given-names></name> <name><surname>Casadesus</surname> <given-names>G.</given-names></name> <name><surname>Gustaw-Rothenberg</surname> <given-names>K.</given-names></name> <name><surname>Siedlak</surname> <given-names>S. L.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Zhu</surname> <given-names>X.</given-names></name> <name><surname>Perry</surname> <given-names>G.</given-names></name> <name><surname>Castellani</surname> <given-names>R. J.</given-names></name> <name><surname>Smith</surname> <given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Frontiers in Alzheimer&#x02019;s disease therapeutics</article-title>. <source>Ther. Adv. Chronic Dis.</source> <volume>2</volume>, <fpage>9</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1177/2040622310382817</pub-id><pub-id pub-id-type="pmid">21743833</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sussman</surname> <given-names>J. L.</given-names></name> <name><surname>Harel</surname> <given-names>M.</given-names></name> <name><surname>Frolow</surname> <given-names>F.</given-names></name> <name><surname>Oefner</surname> <given-names>C.</given-names></name> <name><surname>Goldman</surname> <given-names>A.</given-names></name> <name><surname>Toker</surname> <given-names>L.</given-names></name> <name><surname>Silman</surname> <given-names>I.</given-names></name></person-group> (<year>1991</year>). <article-title>Atomic structure of acetylcholinesterase from <italic>Torpedo californica</italic>: a prototypic acetylcholine-binding protein</article-title>. <source>Science</source> <volume>253</volume>, <fpage>872</fpage>&#x02013;<lpage>879</lpage>.<pub-id pub-id-type="doi">10.1126/science.1678899</pub-id><pub-id pub-id-type="pmid">1678899</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsim</surname> <given-names>K. W.</given-names></name> <name><surname>Randall</surname> <given-names>W. R.</given-names></name> <name><surname>Barnard</surname> <given-names>E. A.</given-names></name></person-group> (<year>1988a</year>). <article-title>An asymmetric form of muscle acetylcholinesterase contains three subunit types and two enzymic activities in one molecule</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>85</volume>, <fpage>1262</fpage>&#x02013;<lpage>1266</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.85.4.1262</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsim</surname> <given-names>K. W.</given-names></name> <name><surname>Randall</surname> <given-names>W. R.</given-names></name> <name><surname>Barnard</surname> <given-names>E. A.</given-names></name></person-group> (<year>1988b</year>). <article-title>Synaptic acetylcholinesterase of chicken muscle changes during development from a hybrid to a homogeneous enzyme</article-title>. <source>EMBO J.</source> <volume>7</volume>, <fpage>2451</fpage>&#x02013;<lpage>2456</lpage>.</citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Velan</surname> <given-names>B.</given-names></name> <name><surname>Kronman</surname> <given-names>C.</given-names></name> <name><surname>Ordentlich</surname> <given-names>A.</given-names></name> <name><surname>Flashner</surname> <given-names>Y.</given-names></name> <name><surname>Leitner</surname> <given-names>M.</given-names></name> <name><surname>Cohen</surname> <given-names>S.</given-names></name> <name><surname>Shafferman</surname> <given-names>A.</given-names></name></person-group> (<year>1993</year>). <article-title>N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis</article-title>. <source>Biochem. J.</source> <volume>296</volume>, <fpage>649</fpage>&#x02013;<lpage>656</lpage>.<pub-id pub-id-type="pmid">8280063</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Chu</surname> <given-names>G. K.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Transcriptional regulation of proline-rich membrane anchor (PRiMA) of globular form acetylcholinesterase in neuron: an inductive effect of neuron differentiation</article-title>. <source>Brain Res.</source> <volume>1265</volume>, <fpage>13</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainres.2009.01.065</pub-id><pub-id pub-id-type="pmid">19368807</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Siow</surname> <given-names>N. L.</given-names></name> <name><surname>Kong</surname> <given-names>L. W.</given-names></name> <name><surname>Lau</surname> <given-names>F. T.</given-names></name> <name><surname>Peng</surname> <given-names>H. B.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Regulation of a transcript encoding the proline-rich membrane anchor of globular muscle acetylcholinesterase</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume>, <fpage>11765</fpage>&#x02013;<lpage>11775</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M608265200</pub-id><pub-id pub-id-type="pmid">17324938</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Liang</surname> <given-names>D.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Zhu</surname> <given-names>K. Y.</given-names></name> <name><surname>Chan</surname> <given-names>W. K.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Massouli&#x000E9;</surname> <given-names>J.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2010a</year>). <article-title>Targeting acetylcholinesterase to membrane rafts: a function mediated by the proline-rich membrane anchor (PRiMA) in neurons</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume>, <fpage>11537</fpage>&#x02013;<lpage>11546</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M110.153676</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>H. Q.</given-names></name> <name><surname>Leung</surname> <given-names>K. W.</given-names></name> <name><surname>Chen</surname> <given-names>V. P.</given-names></name> <name><surname>Chan</surname> <given-names>G. K.</given-names></name> <name><surname>Xu</surname> <given-names>S. L.</given-names></name> <name><surname>Guo</surname> <given-names>A. J.</given-names></name> <name><surname>Zhu</surname> <given-names>K. Y.</given-names></name> <name><surname>Zheng</surname> <given-names>K. Y.</given-names></name> <name><surname>Bi</surname> <given-names>C. W.</given-names></name> <name><surname>Zhan</surname> <given-names>J. Y.</given-names></name> <name><surname>Chan</surname> <given-names>W. K.</given-names></name> <name><surname>Choi</surname> <given-names>R. C.</given-names></name> <name><surname>Tsim</surname> <given-names>K. W.</given-names></name></person-group> (<year>2010b</year>). <article-title>PRiMA directs a restricted localization of tetrameric AChE at synapses</article-title>. <source>Chem. Biol. Interact.</source> <volume>187</volume>, <fpage>78</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.cbi.2010.02.018</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>W.</given-names></name> <name><surname>Stribley</surname> <given-names>J. A.</given-names></name> <name><surname>Chatonnet</surname> <given-names>A.</given-names></name> <name><surname>Wilder</surname> <given-names>P. J.</given-names></name> <name><surname>Rizzino</surname> <given-names>A.</given-names></name> <name><surname>McComb</surname> <given-names>R. D.</given-names></name> <name><surname>Taylor</surname> <given-names>P.</given-names></name> <name><surname>Hinrichs</surname> <given-names>S. H.</given-names></name> <name><surname>Lockridge</surname> <given-names>O.</given-names></name></person-group> (<year>2000</year>). <article-title>Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>293</volume>, <fpage>896</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="pmid">10869390</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zakut</surname> <given-names>H.</given-names></name> <name><surname>Even</surname> <given-names>L.</given-names></name> <name><surname>Birkenfeld</surname> <given-names>S.</given-names></name> <name><surname>Malinger</surname> <given-names>G.</given-names></name> <name><surname>Zisling</surname> <given-names>R.</given-names></name> <name><surname>Soreq</surname> <given-names>H.</given-names></name></person-group> (<year>1988</year>). <article-title>Modified properties of serum cholinesterases in primary carcinomas</article-title>. <source>Cancer</source> <volume>61</volume>, <fpage>727</fpage>&#x02013;<lpage>737</lpage>.<pub-id pub-id-type="doi">10.1002/1097-0142(19880215)61:4&#x0003C;727::AID-CNCR2820610416&#x0003E;3.0.CO;2-L</pub-id><pub-id pub-id-type="pmid">3338035</pub-id></citation></ref>
</ref-list>
</back>
</article>
